MERSİN, S. Et Al. 2021. Evaluation of a Generic Bortezomib Molecule in Newly Diagnosed Multiple Myeloma Patients. TURKISH JOURNAL OF HEMATOLOGY , vol.38, no.3 , 211-217.

MERSİN, S., GEDÜK, A., MEHTAP, Ö., TARKUN, P., ÜNAL, S., POLAT, M. G., ... AYGÜN, K.(2021). Evaluation of a Generic Bortezomib Molecule in Newly Diagnosed Multiple Myeloma Patients. TURKISH JOURNAL OF HEMATOLOGY , vol.38, no.3, 211-217.

MERSİN, SİNAN Et Al. "Evaluation of a Generic Bortezomib Molecule in Newly Diagnosed Multiple Myeloma Patients," TURKISH JOURNAL OF HEMATOLOGY , vol.38, no.3, 211-217, 2021

MERSİN, SİNAN Et Al. "Evaluation of a Generic Bortezomib Molecule in Newly Diagnosed Multiple Myeloma Patients." TURKISH JOURNAL OF HEMATOLOGY , vol.38, no.3, pp.211-217, 2021

MERSİN, S. Et Al. (2021) . "Evaluation of a Generic Bortezomib Molecule in Newly Diagnosed Multiple Myeloma Patients." TURKISH JOURNAL OF HEMATOLOGY , vol.38, no.3, pp.211-217.

@article{article, author={SİNAN MERSİN Et Al. }, title={Evaluation of a Generic Bortezomib Molecule in Newly Diagnosed Multiple Myeloma Patients}, journal={TURKISH JOURNAL OF HEMATOLOGY}, year=2021, pages={211-217} }